Pegfilgrastim ( Neulasta ) from Amgen (Health/Medications)
neulasta.com

Description: Information for patients and doctors about fighting cancer chemotherapy induced neutropenia (white blood cell deficiency) and consequent infections with this medicine. Neulasta pegfilgrastim reduces risks of lifethreatening infections associated with neutropenia (low white blood cell count), one of chemotherapy side effects, in patients who are receiving anticancer drugs or chemotherapy treatment. Ask your doctor about Neulasta when starting chemotherapy to increase white blood cells during cancer treatment

Specializes in: cancer anemia fatigue chemotherapy chemotherapy drugs amgen white blood cells cancer treatment red blood cells low

Website owner:

Registrant:
AMGEN, Inc (DOM-179394)
One Amgen Center Drive
Thousand Oaks CA 91320
US
Domain Name: neulasta.com
Registrar Name: Markmonitor.com
Registrar Whois: whois.markmonitor.com
Registrar Homepage: http://www.markmonitor.com
Administrative Contact:
Patent Operations Department (NIC-1065124) AMGEN, Inc
One Amgen Center Drive MS 27-4-A
Thousand Oaks CA 91320
US
email hidden
1.8054471086
Fax- +1.8054998
Technical Contact, Zone Contact:
Center Network Operations (NIC-1008836) Information Management Group
One Amgen Center Drive MS 10-1-A
Thousand Oaks CA 91320
US
email hidden
1.8054477710
Fax- +1.8054998535
Created on..............: 2002-Jan-11.
Expires on..............: 2014-Jan-11.
Record last updated on..: 2005-Nov-09 15:09:25.
Domain servers in listed order:
NS1.AMGEN.COM 
NS2.AMGEN.COM 
NS3.AMGEN.COM